These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 24204098)
21. Blockade of interleukin-6 signaling suppresses not only th17 but also interphotoreceptor retinoid binding protein-specific Th1 by promoting regulatory T cells in experimental autoimmune uveoretinitis. Haruta H; Ohguro N; Fujimoto M; Hohki S; Terabe F; Serada S; Nomura S; Nishida K; Kishimoto T; Naka T Invest Ophthalmol Vis Sci; 2011 May; 52(6):3264-71. PubMed ID: 21330657 [TBL] [Abstract][Full Text] [Related]
22. Key role for IL-21 in experimental autoimmune uveitis. Wang L; Yu CR; Kim HP; Liao W; Telford WG; Egwuagu CE; Leonard WJ Proc Natl Acad Sci U S A; 2011 Jun; 108(23):9542-7. PubMed ID: 21593413 [TBL] [Abstract][Full Text] [Related]
23. T regulatory cells contribute to the attenuated primary CD8+ and CD4+ T cell responses to herpes simplex virus type 2 in neonatal mice. Fernandez MA; Puttur FK; Wang YM; Howden W; Alexander SI; Jones CA J Immunol; 2008 Feb; 180(3):1556-64. PubMed ID: 18209051 [TBL] [Abstract][Full Text] [Related]
24. Aged regulatory T cells protect from autoimmune inflammation despite reduced STAT3 activation and decreased constraint of IL-17 producing T cells. Sun L; Hurez VJ; Thibodeaux SR; Kious MJ; Liu A; Lin P; Murthy K; Pandeswara S; Shin T; Curiel TJ Aging Cell; 2012 Jun; 11(3):509-19. PubMed ID: 22372596 [TBL] [Abstract][Full Text] [Related]
25. Dynamics of intraocular IFN-γ, IL-17 and IL-10-producing cell populations during relapsing and monophasic rat experimental autoimmune uveitis. Kaufmann U; Diedrichs-Möhring M; Wildner G PLoS One; 2012; 7(11):e49008. PubMed ID: 23155443 [TBL] [Abstract][Full Text] [Related]
26. A Th17-like developmental process leads to CD8(+) Tc17 cells with reduced cytotoxic activity. Huber M; Heink S; Grothe H; Guralnik A; Reinhard K; Elflein K; Hünig T; Mittrücker HW; Brüstle A; Kamradt T; Lohoff M Eur J Immunol; 2009 Jul; 39(7):1716-25. PubMed ID: 19544308 [TBL] [Abstract][Full Text] [Related]
27. Contribution of CD4+CD25+ T cells to the regression phase of experimental autoimmune uveoretinitis. Sun M; Yang P; Du L; Zhou H; Ren X; Kijlstra A Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):383-9. PubMed ID: 19696173 [TBL] [Abstract][Full Text] [Related]
28. The role of LAT in increased CD8+ T cell exhaustion in trigeminal ganglia of mice latently infected with herpes simplex virus 1. Allen SJ; Hamrah P; Gate D; Mott KR; Mantopoulos D; Zheng L; Town T; Jones C; von Andrian UH; Freeman GJ; Sharpe AH; BenMohamed L; Ahmed R; Wechsler SL; Ghiasi H J Virol; 2011 May; 85(9):4184-97. PubMed ID: 21307196 [TBL] [Abstract][Full Text] [Related]
29. Tofacitinib inhibits the development of experimental autoimmune uveitis and reduces the proportions of Th1 but not of Th17 cells. Bing SJ; Lyu C; Xu B; Wandu WS; Hinshaw SJ; Furumoto Y; Caspi RR; Gadina M; Gery I Mol Vis; 2020; 26():641-651. PubMed ID: 33088168 [TBL] [Abstract][Full Text] [Related]
30. IL-27 enhances the survival of tumor antigen-specific CD8+ T cells and programs them into IL-10-producing, memory precursor-like effector cells. Liu Z; Liu JQ; Talebian F; Wu LC; Li S; Bai XF Eur J Immunol; 2013 Feb; 43(2):468-79. PubMed ID: 23225163 [TBL] [Abstract][Full Text] [Related]
31. Interleukin 12 protects from a T helper type 1-mediated autoimmune disease, experimental autoimmune uveitis, through a mechanism involving interferon gamma, nitric oxide, and apoptosis. Tarrant TK; Silver PB; Wahlsten JL; Rizzo LV; Chan CC; Wiggert B; Caspi RR J Exp Med; 1999 Jan; 189(2):219-30. PubMed ID: 9892605 [TBL] [Abstract][Full Text] [Related]
33. Protective effect of the type IV phosphodiesterase inhibitor rolipram in EAU: protection is independent of IL-10-inducing activity. Xu H; Strassmann G; Chan CC; Rizzo LV; Silver PB; Wiggert B; Caspi RR Invest Ophthalmol Vis Sci; 1999 Apr; 40(5):942-50. PubMed ID: 10102291 [TBL] [Abstract][Full Text] [Related]
34. Upregulation of DR3 expression in CD4⁺ T cells promotes secretion of IL-17 in experimental autoimmune uveitis. Qin T Mol Vis; 2011; 17():3486-93. PubMed ID: 22219644 [TBL] [Abstract][Full Text] [Related]
35. An M2 Rather than a T Lee DH; Ghiasi H J Virol; 2018 May; 92(10):. PubMed ID: 29491152 [TBL] [Abstract][Full Text] [Related]
36. Production of IL-35 by Bregs is mediated through binding of BATF-IRF-4-IRF-8 complex to il12a and ebi3 promoter elements. Yu CR; Choi JK; Uche AN; Egwuagu CE J Leukoc Biol; 2018 Dec; 104(6):1147-1157. PubMed ID: 30117603 [TBL] [Abstract][Full Text] [Related]
37. Activated γδ T Cells Promote Dendritic Cell Maturation and Exacerbate the Development of Experimental Autoimmune Uveitis (EAU) in Mice. Wang B; Tian Q; Guo D; Lin W; Xie X; Bi H Immunol Invest; 2021 Feb; 50(2-3):164-183. PubMed ID: 31985304 [TBL] [Abstract][Full Text] [Related]
38. Coordinated gene expression of Th17- and Treg-associated molecules correlated with resolution of the monophasic experimental autoimmune uveitis. Jia X; Hu M; Wang C; Wang C; Zhang F; Han Q; Zhao R; Huang Q; Xu H; Yuan H; Ren H Mol Vis; 2011; 17():1493-507. PubMed ID: 21686325 [TBL] [Abstract][Full Text] [Related]